AAAAAA

   
Results: 1-21 |
Results: 21
HIGH-DOSE MULTIMODALITY THERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FORSTAGE IIIB BREAST-CARCINOMA
Authors: AYASH LJ ELIAS A IBRAHIM J SCHWARTZ G WHEELER C REICH E LYNCH C WARREN D SHAPIRO C RICHARDSON P HURD D SCHNIPPER L FREI E ANTMAN K
Citation: Lj. Ayash et al., HIGH-DOSE MULTIMODALITY THERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FORSTAGE IIIB BREAST-CARCINOMA, Journal of clinical oncology, 16(3), 1998, pp. 1000-1007
THE COURSE OF MY LIFE - MY AUTOBIOGRAPHY - HEATH,E
Authors: HURD D
Citation: D. Hurd, THE COURSE OF MY LIFE - MY AUTOBIOGRAPHY - HEATH,E, TLS. Times literary supplement, (4987), 1998, pp. 7-8
REPETITIVE CYCLES OF CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN INTENSIFICATION WITH PERIPHERAL-BLOOD PROGENITOR CELLS AND FILGRASTIM IN ADVANCED BREAST-CANCER PATIENTS
Authors: SHAPIRO CL AYASH L WEBB IJ GELMAN R KEATING J WILLIAMS L DEMETRI G CLARK P ELIAS A DUGGAN D HAYES D HURD D HENDERSON IC
Citation: Cl. Shapiro et al., REPETITIVE CYCLES OF CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN INTENSIFICATION WITH PERIPHERAL-BLOOD PROGENITOR CELLS AND FILGRASTIM IN ADVANCED BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(2), 1997, pp. 674-683
MOLECULAR CHARACTERIZATION OF THE T(8-13)(P11-Q12) TRANSLOCATION ASSOCIATED WITH AN ATYPICAL MYELOPROLIFERATIVE DISORDER - EVIDENCE FOR 3 DISCRETE LOCI INVOLVED IN MYELOID LEUKEMIAS ON 8P11
Authors: STILL IH CHERNOVA O HURD D STONE RM COWELL JK
Citation: Ih. Still et al., MOLECULAR CHARACTERIZATION OF THE T(8-13)(P11-Q12) TRANSLOCATION ASSOCIATED WITH AN ATYPICAL MYELOPROLIFERATIVE DISORDER - EVIDENCE FOR 3 DISCRETE LOCI INVOLVED IN MYELOID LEUKEMIAS ON 8P11, Blood, 90(8), 1997, pp. 3136-3141
A MULTICENTER PHASE-II TRIAL OF CD-34-BLOOD STEM-CELLS (PBSC) AND HIGH-DOSE CYCLOPHOSPHAMIDE (CY), VP-16, CARBOPLATIN (CB) AND TOTAL-BODY IRRADIATION (TBI) FOR RECURRENT NON-HODGKINS-LYMPHOMA (NHL)( PERIPHERAL)
Authors: SHEA T PERRY J BROWN R YANOVICH S WILEY J HURD D DIPERSIO J PONE B CLAPP K JACOBS C
Citation: T. Shea et al., A MULTICENTER PHASE-II TRIAL OF CD-34-BLOOD STEM-CELLS (PBSC) AND HIGH-DOSE CYCLOPHOSPHAMIDE (CY), VP-16, CARBOPLATIN (CB) AND TOTAL-BODY IRRADIATION (TBI) FOR RECURRENT NON-HODGKINS-LYMPHOMA (NHL)( PERIPHERAL), Blood, 88(10), 1996, pp. 463-463
HIGH-DOSE CYCLOPHOSPHAMIDE (CY) AND TOTAL-BODY IRRADIATION (TBI) WITHAUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION FOR POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - OUTCOME ANALYSIS BY HISTOLOGIC GRADE AND DISEASE STATUS AT TRANSPLANT
Authors: PERRY J CASE D SHIPLEY D MELISKO M CRUZ JM RADFORD J GREVEN K HURD D
Citation: J. Perry et al., HIGH-DOSE CYCLOPHOSPHAMIDE (CY) AND TOTAL-BODY IRRADIATION (TBI) WITHAUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION FOR POOR-PROGNOSIS NON-HODGKINS-LYMPHOMA (NHL) - OUTCOME ANALYSIS BY HISTOLOGIC GRADE AND DISEASE STATUS AT TRANSPLANT, Blood, 88(10), 1996, pp. 464-464
REMISSION DURATION INVERSIONS FOLLOWING HIGH-DOSE THERAPY AND AUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION FOR RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL)
Authors: PERRY J CASE D SHIPLEY D MELISKO M CRUZ J RADFORD J FERREE C HURD D
Citation: J. Perry et al., REMISSION DURATION INVERSIONS FOLLOWING HIGH-DOSE THERAPY AND AUTOLOGOUS HEMATOPOIETIC-CELL TRANSPLANTATION FOR RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL), Blood, 88(10), 1996, pp. 465-465
THE EFFECT OF ANTI-B4-BLOCKED RICIN (ANTI-B4-BR) ON MINIMAL - RESIDUAL DISEASE (MRD) IN ADULTS WITH B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) (CALGB-9311, CALGB-8762, CALGB-8763)
Authors: SZATROWSKI TP LARSON RA DODGE R SKLAR J REYNOLDS C WESTBROOK CA HURD D KOLITZ J VELEZGARCIA E FRANKEL SR STEWART C BLOOMFIELD CD SCHIFFER CA
Citation: Tp. Szatrowski et al., THE EFFECT OF ANTI-B4-BLOCKED RICIN (ANTI-B4-BR) ON MINIMAL - RESIDUAL DISEASE (MRD) IN ADULTS WITH B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) (CALGB-9311, CALGB-8762, CALGB-8763), Blood, 88(10), 1996, pp. 2665-2665
PHASE-I CLINICAL-TRIAL OF SEROTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA WITH AN IMMUNOGLOBULIN-M MONOCLONAL-ANTIBODY TO CD15
Authors: BALL ED SELVAGGI K HURD D HERZIG R CLARK L MALLEY V PERSICHETTI J DEMAGELHAUSSILVERMAN M
Citation: Ed. Ball et al., PHASE-I CLINICAL-TRIAL OF SEROTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA WITH AN IMMUNOGLOBULIN-M MONOCLONAL-ANTIBODY TO CD15, Clinical cancer research, 1(9), 1995, pp. 965-972
SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) THERAPY FOR LYMPHOMA - RESULTS OF A PHASE-III MULTICENTER STUDY
Authors: FAY JW FELSER JM ABBOUD C BORSON R FREYTES C HERZIG R HURD D JANAKIRAMAN N JANSEN J LAZARUS H LYNCH JP MANGAN KF SAEZ R STEVENS DA WOLFF SN YANOVICH S STIFF P
Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) THERAPY FOR LYMPHOMA - RESULTS OF A PHASE-III MULTICENTER STUDY, Blood, 86(10), 1995, pp. 875-875
T-CELL DEPLETION IN UNRELATED-DONOR MARROW TRANSPLANTATION
Authors: HOWE C WAGNER J KERNAN N HURD D BISHOP M GINGRICH R KURTZBERG J CASPER J HENSLEEDOWNEY J PHILLIPS G THOMPSON J DONNENBERG A LONG G YANOVICH S CARTERCAMPBELL S
Citation: C. Howe et al., T-CELL DEPLETION IN UNRELATED-DONOR MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 1551-1551
ANTI-B4-BLOCKED RICIN AS CONSOLIDATION THERAPY FOR PATIENTS WITH B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PHASE-II TRIAL (CALGB-9311)
Authors: SZATROWSKI TP LARSON RA GEORGE S DODGE R HURD D KOLITZ J VELEZGARCIA E SKLAR J REYNOLDS C WESTBROOK CA FRANKEL SR STEWART C BLOOMFIELD CD SCHIFFER CA
Citation: Tp. Szatrowski et al., ANTI-B4-BLOCKED RICIN AS CONSOLIDATION THERAPY FOR PATIENTS WITH B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PHASE-II TRIAL (CALGB-9311), Blood, 86(10), 1995, pp. 3119-3119
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR A PATIENT WITH ACUTE-LEUKEMIA AND END-STAGE RENAL-DISEASE (ESRD) - CLINICAL COURSE AND PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE (CTX)
Authors: PERRY J FLEMING R BLEYER A PETROS W ROCCO M RADFORD J POWELL B HURD D
Citation: J. Perry et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR A PATIENT WITH ACUTE-LEUKEMIA AND END-STAGE RENAL-DISEASE (ESRD) - CLINICAL COURSE AND PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE (CTX), Blood, 86(10), 1995, pp. 3831-3831
TOO FEW DIVERSE TRAINERS
Authors: HURD D
Citation: D. Hurd, TOO FEW DIVERSE TRAINERS, Training & development, 48(6), 1994, pp. 4
TRISOMY-5 AS THE SOLE ABNORMALITY IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A2ND CASE AND REVIEW
Authors: RAO PN BUSS D BROWN S OCONNOR M HURD D PETTENATI MJ
Citation: Pn. Rao et al., TRISOMY-5 AS THE SOLE ABNORMALITY IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A2ND CASE AND REVIEW, Cancer genetics and cytogenetics, 75(2), 1994, pp. 117-119
SALVAGE THERAPY FOR RECURRENT AND REFRACTORY OVARIAN-CANCER WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY
Authors: BROUN ER BELINSON JL BEREK JS MCINTOSH D HURD D BALL H WILLIAMS S
Citation: Er. Broun et al., SALVAGE THERAPY FOR RECURRENT AND REFRACTORY OVARIAN-CANCER WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY, Gynecologic oncology, 54(2), 1994, pp. 142-146
DEVELOPING THE COMMON FOREIGN AND SECURITY POLICY
Authors: HURD D
Citation: D. Hurd, DEVELOPING THE COMMON FOREIGN AND SECURITY POLICY, International affairs, 70(3), 1994, pp. 421-428
IMPROVED OUTCOME FOR HIGH-RISK ACUTE MYELOID-LEUKEMIA PATIENTS USING AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND MONOCLONAL ANTIBODY-PURGED BONE-MARROW
Authors: SELVAGGI KJ WILSON JW MILLS LE CORNWELL GG HURD D DODGE W GINGRICH R MARTIN SE MCMILLAN R MILLER W BALL ED
Citation: Kj. Selvaggi et al., IMPROVED OUTCOME FOR HIGH-RISK ACUTE MYELOID-LEUKEMIA PATIENTS USING AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND MONOCLONAL ANTIBODY-PURGED BONE-MARROW, Blood, 83(6), 1994, pp. 1698-1705
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER
Authors: PETERS WP ROSS M VREDENBURGH JJ MEISENBERG B MARKS LB WINER E KURTZBERG J BAST RC JONES R SHPALL E WU K ROSNER G GILBERT C MATHIAS B CONIGLIO D PETROS W HENDERSON IC NORTON L WEISS RB BUDMAN D HURD D
Citation: Wp. Peters et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW SUPPORT AS CONSOLIDATION AFTER STANDARD-DOSE ADJUVANT THERAPY FOR HIGH-RISK PRIMARY BREAST-CANCER, Journal of clinical oncology, 11(6), 1993, pp. 1132-1143
MONOCLONAL-ANTIBODY SEROTHERAPY IN CONJUNCTION WITH CHEMOTHERAPY FOR RELAPSED ACUTE MYELOID-LEUKEMIA (AML)
Authors: SELVAGGI K HURD D SPRINGGATE C HERZIG R RYBKA WB DEMAGALHAESSILVERMAN M BALL ED
Citation: K. Selvaggi et al., MONOCLONAL-ANTIBODY SEROTHERAPY IN CONJUNCTION WITH CHEMOTHERAPY FOR RELAPSED ACUTE MYELOID-LEUKEMIA (AML), Blood, 82(10), 1993, pp. 10000131-10000131
THE EFFECT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL AND MARROW CELL DOSE ON WBC AND PLATELET RECOVERY IN A VARIED PATIENT TREATMENT GROUP
Authors: HALEY R DODGE W SHARMA S SLEDGE L RIKE K CRUZ J PERRY J HURD D
Citation: R. Haley et al., THE EFFECT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL AND MARROW CELL DOSE ON WBC AND PLATELET RECOVERY IN A VARIED PATIENT TREATMENT GROUP, Blood, 82(10), 1993, pp. 10000632-10000632
Risultati: 1-21 |